2nd Jun 2015 06:58
LONDON (Alliance News) - Plant Health Care PLC on Tuesday said it has signed a new evaluation agreement with an agriculture company related to its Innatus 3G peptide platform.
Innatus technology enables the design, screening and production of a large pipeline of peptides with diverse bio-stimulant properties. The peptides can provide improved yields, pest and disease resistance, and protection against abiotic stress in a wide range of crops, Plant Health Care said.
No financial details were disclosed on the agreement.
"Our goal was to sign at least two evaluation agreements for our Innatus 3G peptide platform this year and we have accomplished that within the first five months. We are targeting the largest players and these agreements reflect the potential value they see in our platform. Our dialogue with other major players is on-going," said Paul Schmidt, Plant Health Care's chief executive.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
PHC.L